Monoclonal antibody inhibits tumor growth in angiosarcoma and breast cancer

[News]

A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma.

More... (http://www.news-medical.net/news/20130420/Monoclonal-antibody-inhibits-tumor-growth-in-angiosarcoma-and-breast-cancer.aspx)